West Pharmaceutical Services, a provider of solutions for injectable drug administration, reports that Amgen Inc. has used West's Daikyo Crystal Zenith (CZ) vials, in conjunction with West FluroTec stoppers, to contain Amgen’s Imlygic (talimogene laherparepvec), an oncolytic viral therapy indicated for treating. melanoma. Manufactured from a cyclic olefin polymer, CZ vials offer an alternative to glass vials.

The CZ container closure system also includes a West FluroTec stopper, which provides a barrier against extractables without compromising seal integrity.

Source: West Pharmaceutical Services